comparemela.com

Latest Breaking News On - Glen clack - Page 2 : comparemela.com

Investegate |Evgen Pharma PLC Announcements | Evgen Pharma PLC: Full Year Results

Investegate |Evgen Pharma PLC Announcements | Evgen Pharma PLC: Grant of Options

Evgen appoints Glen Clack as chief medical officer | 26 April 2021

26 April 2021 | 09:34am StockMarketWire.com - Clinical stage drug development company Evgen said had appointed Glen Clack, MD, FFPM as chief medical officer starting from 1 May 2021. Clack has over 30 years experience in oncology and translational medicine, and held various roles within AstraZeneca for almost 20 years, the company said. At 9:34am: [LON:EVG] Evgen Pharma Plc share price was 0p at 8.3p Story provided by StockMarketWire.com Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Latest share price and company details:

Evgen Appointment of Chief Medical Officer

Evgen Appointment of Chief Medical Officer Search jobs Evgen Appointment of Chief Medical Officer Evgen (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer, inflammation and acute respiratory distress syndrome, announces that Glen Clack, MD, FFPM will be joining the Company as Chief Medical Officer effective from 1 May 2021. Dr Clack has over 30 years experience in oncology and translational medicine, and held various roles within AstraZeneca for almost 20 years. Dr Clack has specialised in early phase oncology clinical development with an emphasis on a number of important cancers and has a wealth of experience in conducting and managing clinical trials. He has successfully provided strategic and operational leadership from Phase I through to regulatory submissions and commercialisation. He has been a lead member of study, clinical development and project teams on multiple trials.

Evgen Pharma PLC appoints new chief medical officer

Evgen Pharma PLC appoints new chief medical officer
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.